This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Risk of recurrence of hypertensive disorders of pregnancy (if previous hypertension in pregnancy)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Risk of recurrence of hypertensive disorders of pregnancy

Advise women with hypertensive disorders of pregnancy that the overall risk of recurrence in future pregnancies is approximately 1 in 5 (see table below)

Prevalence of hypertensive disorder in a future pregnancy

Any hypertension in pregnancy

Pre-eclampsia

Gestational hypertension

Any hypertension

Approximately 21% (1 in 5 women)

Approximately 20% (1 in 5 women)

Approximately 22% (1 in 5 women)

Pre-eclampsia

Approximately 14% (1 in 7 women)

Up to approximately 16%

(1 in 6 women)

If birth was at 28-34 week (a) approximately 33% (1 in 3 women)

If birth was at 34-37 weeks: pproximately 23% (1 in 4 women)

Approximately 7% (1 in 14 women)

Gestational hypertension

Approximately 9%

(1 in 11 women)

Between approximately 6 and 12%

(up to 1 in 8 women)

Between approximately 11 and 15%

(up to 1 in 7 women)

Chronic hypertension

Not applicable

Approximately 2%

(up to 1 in 50 women)

Approximately 3%

(up to 1 in 34 women)

a) No evidence was identified for women who gave birth at less than 28 weeks, but the committee agreed that the risk was likely to be at least as high, if not higher, than that for women who gave birth between 28 and 34 weeks.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.